Total
0
Shares
Universal Biosensors (ASX:UBI) - CEO, John Sharman
CEO, John Sharman
Source: The Market Herald
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Universal Biosensors (UBI) enters into a collaboration agreement with Mayo Clinic Biopharma Diagnostics
  • Mayo Clinic is one of the world’s most prestigious oncology research and treatment institutions
  • The agreement covers multiple projects including UBI’s Tn antigen cancer biosensor and is for a three year term
  • On market close for the day, Universal Biosensors was up 1.89 per cent to trade at 81 cents per share

Universal Biosensors (UBI) has entered into a collaboration agreement with Mayo Clinic Biopharma Diagnostics.

Mayo Clinic is one of the world’s most prestigious oncology research and treatment institutions based in Rochester Minnesota, US. The business is focused on integrated healthcare, education and research.

The agreement covers multiple projects including UBI’s Tn antigen cancer biosensor, a handheld device that can accurately measure a patient’s cancer status through monitoring of remission and recurrence.

The agreement is for a three year period and includes standard termination options.

UBI designs and develops electrochemical cells for use together with point-of-use devices across the healthcare, wine, food and agriculture industries.

Last month, Universal Biosensors signed a non-exclusive distribution deal with Vivelys SAS to distribute its Sentia wine testing platform device.

The wine testing platform is a new product and is currently being launched around the globe.

Vivelys is based in France and is focused on the analysis of grape vines and the ageing of wines in oak barrels through every stage of the winemaking process.

The parties’ distribution deal also had a three-year term.

On market close for the day, Universal Biosensors was up 1.89 per cent and to trade at 81 cents per share.

UBI by the numbers
More From The Market Herald
The Market Herald Video

" Security Matters (ASX:SMX): Addressing fashion’s $40-billion problem

Australian company Security Matters is taking the lead in helping the fashion industry’s attempts to address a $40-billion problem.
Adriatic Metals PLC (ASX:ADT) - CEO, Paul Cronin

" Adriatic Metals (ASX:ADT) releases silver assays for Rupice Mineral Resource

Adriatic Metals (ADT) has released silver assays for its wholly-owned Vares Silver Project in Bosnia and Herzegovina.
Turaco Gold (ASX:TCG) -Managing Director, Justin Tremain

" Turaco Gold (ASX:TCG) receives results from Bouake North

Turaco Gold (TCG) has received results from its recently completed auger drilling program at the Bouake North prospect in Côte d’Ivoire.
Ensurance (ASX:ENA) - Incoming Non-executive Chairman, Tony Leibowitz

" Ensurance (ASX:ENA) appoints new CEO

Ensurance (ENA) has appointed Mr Tom Kent as CEO, effective from January 1, 2022.